SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs rally is drawing attention to Morgan Stanleys bullish call and plans for a Florida methane pipeline to support Starship launches, alongside the companys AI and chipmaking ambitions. Bulls point to momentum and possible short-covering, while skeptics argue the valuation is stretched and upcoming share unlocks could add selling pressure.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavaxs sharp rally is being linked by traders to headlines about a suspected plague exposure at a Russian research lab, with many speculating that the move could trigger a short squeeze given the stocks elevated short interest. Others argue the outbreak story is only part of the interest, pointing to Nuvaxovid approvals and the Sanofi and Takeda partnerships, while some caution that the rally may be driven by FOMO and could fade.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias breakout to fresh highs amid strength in AI and technology stocks is driving the conversation, with bulls pointing to durable AI-infrastructure demand and potential short-covering. Skeptics counter that high valuations and concerns about AI spending and financing could leave the stock vulnerable to profit-taking.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is drawing attention amid a weak share-price trend and uncertainty over how it will finance its planned AI data-center projects, with traders concerned about convertible debt, dilution and limited filing-level detail. Bulls point to large contracts and GPU deployments moving toward execution, while skeptics say the company must show clearer financing terms and convert those projects into revenue and cash flow.

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

A sharp momentum rally and breakout has traders focused on Ginkgos AI-driven autonomous-lab pivot and pharma partnerships as a possible re-rating catalyst, with some speculating about a short squeeze. Bulls see the biology-infrastructure story gaining traction, while skeptics question whether it can translate into revenue and warn about dilution risk.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is drawing attention after Elon Musk confirmed discussions about a possible role in the Terafab chip project in Texas, alongside a breakout to fresh highs. Traders are broadly bullish, though they note no agreement is finalized and debate whether TSMC would supplement or replace Intel as a manufacturing partner.

iShares Inc. - iShares MSCI Brazil ETF

iShares MSCI Brazil ETF

Brazilian equities surged after right-wing challenger Flvio Bolsonaro outperformed expectations in the first round of the presidential election, setting up a runoff against incumbent Lula. Traders largely welcomed the prospect of a more business-friendly government, while the unresolved runoff and political uncertainty remain sources of risk.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Figure Technology Solutions, Inc. is a blockchain-native capital marketplace, which engages in connecting origination, funding, and secondary market activity. It operates through the following segments: FTI, Markets, and Other. The FTI segment offers Figure Connect which generates ecosystem and technology fees, and originates, sells, and securitizes home equity line of credit (HELOC) loans that it services. The Markets segment utilizes blockchain technology to develop an exchange for digital assets and credit, with new product offerings including providing interest-bearing stable coin deposits. The company was founded by Michael Scott Cagney and June Ou in 2018 and is headquartered in Reno, NV.

Figure Technology Solutions Inc. - Ordinary Shares - Class A

Figure Technology Solutions Inc

FIGR is drawing attention for a steep, extended selloff, with traders highlighting repeated down sessions and debating whether insider selling and weak price action signal further trouble. Bears raise scam or bankruptcy fears, while bulls counter with the companys reported profitability, loan-marketplace growth, and tokenization opportunity.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Michael Burrys reported Deckers position as a temporary proxy for Lululemon is drawing attention, with some traders treating the move as a vote of confidence and others joking that his involvement is a bad omen. The discussion also reflects broader concern about footwear-sector weakness and Deckers persistent share-price pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Decoy Therapeutics Reports Preclinical Data For Weekly Intranasal DCOY-CoV

(RTTNews) - Tuesday, Decoy Therapeutics (DCOY) said preclinical pharmacokinetic data support once-weekly intranasal dosing of its lead program DCOY-CoV, designed to protect against endemic human coronaviruses...

Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program

Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV ProgramPR NewswireCAMBRIDGE, Mass., Sept. 29, 2026 Once-Weekly Intranasal Potential...

Catalysts Keeping Momentum Going

Today’s tape is driven by catalysts; from a proposed balance-sheet reset at Beneficient (NASDAQ:BENF) to others for Wheeler REIT (NASDAQ:WHLR), Decoy Therapeutics (NASDAQ:DCOY), Greenland Mines Ltd. (NASDAQ:GRML), NeOnc Technologies Holdings (NASDAQ:NTHI), Professional Diversity Network (NASDAQ:IPDN), and Maison Solutions (NASDAQ:MSS).

Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release

Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press ReleasePR NewswireHOUSTON, Sept. 22, 2026 HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY)(the...

Stocks Riding Compelling Catalysts

Among the listings positioned for strong sessions are Rain Enhancement Technologies (NASDAQ:RAIN), Butterfly Network (NYSE:BFLY), NeOnc Technologies Holdings (NASDAQ:NTHI), Surgery Partners (NASDAQ:SGRY), Omeros (NASDAQ:OMER), Ginkgo Bioworks (NYSE:DNA), and bioAffinity (NASDAQ:BIAF). Meanwhile, Decoy Therapeutics (NASDAQ:DCOY), Filana Therapeutics (NASDAQ:FLNA), Jaguar Health (NASDAQ:JAGX), Maze Therapeutics (NASDAQ:MAZE), Viking Therapeutics (NASDAQ:VKTX), Greenland Mines (NASDAQ:GRML), and Lianhe Sowell International (NASDAQ:LHSW) remain squarely on the market's high-catalyst radar.

Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules

Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq RulesPR...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

Decoy Therapeutics (NASDAQ:DCOY) shares rose 84.0% to $4.71 during Tuesday's pre-market session. The company's market cap stands at $1.6 million.
Greenland Mines (NASDAQ:GRML) shares rose 39.21% toread more...

Ebola Surprise Puts Decoy’s AI Antiviral Platform on a Much Bigger Stage

Decoy Therapeutics (NASDAQ:DCOY) is suddenly talking about viruses far beyond the respiratory diseases at the center of its original development strategy, as an unexpected laboratory result could open an entirely new biodefense opportunity.

Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding

Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive FundingPR NewswireCAMBRIDGE, Mass., Sept. 22, 2026 Next-Generation D-MAVs Demonstrate Potent In...

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform PR Newswire CAMBRIDGE, Mass., Aug. 3, 2026 Portfolio now...

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.

Decoy Therapeutics Inc.

DCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally?

Equity

Bearish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be this week?

Current Price	$1.67
Prev Close	$1.77
Open	$1.77
Dividend Yield	0.00%
50-Day Moving Average	$3.23
Beta	0.22
Avg. Volume	6.47M
PE Ratio	-0.04

52-Week High	$55.92
52-Week Low	$1.61
Market Capitalization	$3.26M
EPS (Annual)	-$129.10
Price to Book	0.22
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

DCOY Fundamentals